Vancouver-Based Nanomedicine Startup Targets Genetic Solution to Diseases

Press Release

February 25, 2016

February 25, 2016 – Vancouver, BC, Canada

The Vancouver Sun recently featured Precision NanoSystems in the health section to highlight the NanoAssemblr Platform as the next generation manufacturing platform for nanomedicines.

Randy Shore of the Vancouver Sun writes, “Using the unique physics of fluids at the nano-scale, the NanoAssemblr combines active ingredients — such as therapeutic strands of DNA or RNA — with complementary particles such as fatty molecules to form a kind of armoured transport. The active ingredients are encapsulated until they reach their target.”

Read the full article and view the interview with Precision NanoSystems’ CEO and co-founder, James Taylor.


IN THE NEWS

Press Release

RNAi (RNA interference) is a revolution in biology, representing a breakthrough in understanding how genes are turned on and off in cells, and a completely new approach to drug dis...

Read More


Press Release

Genome BC congratulates Precision NanoSystems, Inc. (PNI) on the completion of their $13.4 million private Series A financing. PNI will use the funding to expand product development, increase manufacturing capacity and accelerate commercialization ...

Read More